HIGHLIGHTS
- who: Vincenzo Di Stefano and colleagues from the University of Palermo, Palermo, Italy have published the research work: Patisiran Enhances Muscle Mass after Nine Months of Treatment in ATTRv Amyloidosis: A Study with Bioelectrical Impedance Analysis and Handgrip Strength, in the Journal: Biomedicines 2023, 11, 62. of 13/07/2020
- what: Punctual and detailed instrumental biomarkers are in demand for ATTRv to measure the severity of the disease burden and to monitor progression and/or response to treatment.
- how: In this study instrumental data by means of handgrip strength and BIA were systematically . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.